Chris Hancock

Birthplace: Bath, United Kingdom
CTO and Founder, Creo Medical Group PLC 
Chair in Medical Microwave Engineering, Bangor University 

“Driven by innovating to provide better clinical outcomes for patients the world over, Chris has used his knowledge of microwave engineering and analogue circuit design to develop endoscopic therapeutic devices with advanced energy surgical capabilities - devices that are now transforming lives daily.” 

Chris Hancock has focussed his career on microwave engineering and analogue circuit design techniques to enable minimal or non-invasive open surgery, thereby improving patient outcomes. He is a chartered engineer, physicist and prolific inventor in electronic instrumentation design, having authored over 150 patent families. With each family protected in multiple territories, this represents over 1500 granted and pending patents worldwide. He received the 2019 Katharine Burr Blodgett Gold Medal and Prize for his work in designing and developing a new system to treat a range of cancers and won the Inaugural Junkosha Technology Innovator of the Year Award 2022 for his work using high frequency microwave energy to treat cancer. Chris is a Fellow of multiple institutions, including the Royal Academy of Engineering, is a senior member of the IEEE, a Royal Academy of Engineering Visiting Professor at UCL and an Honorary Professor in Cardiff's School of Medicine. 

linkedin.com/company/creo-medical/
twitter.com/CreoMedical
facebook.com/CreoMedical/